Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure

European Journal of Heart Failure

Volumn 15, Issue 9, 2013, Pages 1044-1052

  Reil, Jan Christian ^a   Robertson, Michele ^b   Ford, Ian ^b   Borer, Jeffrey ^c   Komajda, Michel ^d   Swedberg, Karl ^e   Tavazzi, Luigi ^f   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Research Ettore Sansavini Health Science Foundation   (Italy)

Author keywords

Heart failure; Heart rate; Ivabradine; Left bundle branch block

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IVABRADINE; PLACEBO;

ADULT; AGED; ARTICLE; BLURRED VISION; BRADYCARDIA; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DEATH; DIURETIC THERAPY; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC HEART FAILURE; UNSPECIFIED SIDE EFFECT;

HEART FAILURE; HEART RATE; IVABRADINE; LEFT BUNDLE BRANCH BLOCK;

AGED; BENZAZEPINES; BUNDLE-BRANCH BLOCK; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84883197696     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft072     Document Type: Article

References (33)

1. Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, Pepine CJ. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the International Verapamil-SR/trandolapril Study (INVEST). Eur Heart J 2008;29:1327-1334. (Pubitemid 351768127)
2. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-974. (Pubitemid 40695027)
3. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 2010;376:886-894.
4. Swedberg K, Komajda M, Böhm M, Borer J, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled trial. Lancet 2010;376:875-885.
5. Shamim W, Francis DP, Yousufuddin M, Varney S, Pieopli MF, Anker SD, Coats AJ. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 1999;70:171-178. (Pubitemid 29354368)
6. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, Campana C, Perini G, Deorsola A, Masotti G, Tavazzi L, Maggioni AP; Italian Network on Congestive Heart Failure Investigators. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian Network on Congestive Heart Failure. Am Heart J 2002;143:398-405. (Pubitemid 34185169)
7. Lewinter C, Torp-Pedersen C, Cleland JG, Kober L. Right and left bundle branch block as predictors of long-term mortality following myocardial infarction. Eur J Heart Fail 2011;13:1349-1354.
8. Bader H, Garrigue S, Lafitte S, Reuter S, Jais P, Haissaguerre M, Bonnet J, Clementy J, Roudaut R. Intra-left ventricular electromechanical asynchrony.A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004;43: 248-256. (Pubitemid 38201152)
9. Xiao HB, Lee CH, Gibson DG. Effectof left bundle branch blockondiastolic function in dilated cardiomyopathy. Br Heart J 1991;66:443-447.
10. Xiao HB, Brecker SJD, Gibson DG. Effectsofabnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J 1992;68: 403-407.
11. Vernooy K, Verbeek XAAM, Peschar M, Crijns HJGM, Arts T, Cornelussen RNM, Prinzen FW. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 2005;26:91-98. (Pubitemid 40221129)
12. Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA. Regional alterationsinprotein expressioninthe dyssynchro-nous failing heart. Circulation 2003;108:929-932. (Pubitemid 37048220)
13. Moya A, Garcia-Civera R, Corci F, Menozzi C, Brugada J, Ammirati F, Del Rosso A, Bellver-Navarro A, Garcia-Sacristán J, Bortnik M, Mont L, Ruiz-Granell R, Navarro X; on behalf of the Bradycardia detection in Bundle Branch Block (B4) study. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J 2011;32:1535-1541.
14. Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L, Alvarez M, Errazquin F, Beiras J, Bottonie N, Donateo P, on behalf of the ISSUE Investigators. Mechanism of syncope in patients with bundle branch block and negative electrophysiological test. Circulation 2001;104:2045-2050. (Pubitemid 33028910)
15. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Tavazzi L. Rationale and design of a randomised, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the systolic heart failure treatment with the I(f) Inhibitor Ivab-radine Trial (SHIFT). Eur J Heart Fail 2010;12:75-81.
16. Wiggers CJ. Are ventricular conduction changes important in the dynamics of ventricular contraction? Am J Physiol 1926;74:12-30.
17. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asyn-chrony. Circulation 1989;79:845-853. (Pubitemid 19100544)
18. O'Keefe JH, Abuissa H, Jones PG, Thompson RC, Bateman TM, McGhie AI, Ramza BM, Steinhaus DM. Effectofchronic right ventricular apical pacingonleft ventricular function. Am J Cardiol 2005;95:771-773. (Pubitemid 40332659)
19. Sharma AD, Rizo-Patron C, Hallstrom AP, O'Neill GP, Rothbart S, Martins JB, Roelke M, Steinberg JS, Greene HL; DAVID Investigators. Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2005;2:830-834. (Pubitemid 41030726)
20. Ypenburg C, Lancellotti P, Tops LF, Boersma E, Bleeker GB, Holman ER, Thomas JD, Schalij MJ, Piérard LA, Bax JJ. Mechanism of improvementinmitral regurgitation after cardiac resynchronization therapy. Eur Heart J 2008;29:757-765 (Pubitemid 351431034)
21. Ukkonen H, Beanlands RS, Burwash IG, de Kemp RA, Nahmias C, Fallen E, Hill MR, Tang AS. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation 2003;107:28-31. (Pubitemid 36070928)
22. Sogaard P, Kim WY, Jensen HK, Mortensen P, Pedersen AK, Kristensen BØ, Egeblad H. Impact of acute biventricular pacing on left ventricular performance and volumes in patients with severe heart failure: a tissue Doppler and three-dimensional echocardiography study. Cardiology 2001;95:173-183.
23. Prestle J, Dieterich S, Preuss M, Bieligk U, Hasenfuss G. Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart. Cardiovasc Res 1999;43:323-331. (Pubitemid 29356370)
24. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
25. Hasenfuss G, Holubarsch C, Hermann AP, Astheimer K, Pieske B, Just H. Influence of the force-frequency relationship onhaemodynamics and left ventricular function in patients with nonfailing hearts and in patients with dilated cardiomyopathy. Eur Heart J 1994;15:164-170. (Pubitemid 24110691)
26. Böhm M, La Rosee K, Schmidt U, Schulz C, Schwinger RHG, Erdmann E. Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure. Clin Invest 1992;70:421-425.
27. Cullington D, Goode KM, Clark AL, Cleland JG. Heart rate achieved or beta-blocker dosageinpatients with chronic heart failure: whichisthe better target? EurJ Heart Fail 2012;14:737-747.
28. Moss AJ, Hall WJ, Cannom DS, Kein H, Brown MW, Daubert JP, Estes MNA III, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, for the MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart failure events. N Engl J Med 2009;361: 1329-1338.
29. Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, for the RAFT Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-2395.
30. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, fortheCOMPANION Investigators. Cardiac-resynchronization therapy with orwithoutan implantable de-fibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150
31. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
32. Böhm M, Borer J, Ford I, Gonzelez-Juanatey JR, Komajda M, Lopez-Sendon J, Reil JC, Swedberg K, Tavazzi L. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study. Clin Res Cardiol 2013;102:11-22.
33. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA, Böhm M. Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007;28:2568-2577. (Pubitemid 350071511)